International Oncology Network - Cancer & Hematology News
February 2010 Blog Posts (2)
Gene therapy, how with the use of gene therapy, a liver cell can be genetically changed.
Added by Freddy Peters on February 10, 2010 at 2:30am — No Comments
Cancer Tutorial: DNA Topoisomerases as Targets of Anti-cancer Agents
The human genome consists of approximately 3.2 billion base pairs and would be about 2 meters in length, if stretched out from end to end (Porter et al., 2004). Nevertheless, DNA squeezes into the nucleus of a cell, which is approximately 6uM in diameter. For example, the smallest human chromosome is 14 mm long but is compacted to just 2 uM in length (Ball, 2003). Thus, DNA exists in a tightly compacted and dense form. Conversely, DNA must also allow itself to become accessible to numerous… Continue
Added by Roxanne Engel, PhD on February 3, 2010 at 7:21pm — No Comments
Featured Blog Posts
- Trial of T-Cells Genetically-Engineered to Express an Anti-CD19 Chimeric Antigen Receptor Show Promise as NewTtreatment Approach for B-cell Malignancies
- New Finding Pinpoints a Critical Gene Involved in Melanoma Growth and Provides a Framework for Discovering Ways to Tackle Cancer Drug Resistance
- Personalized Cancer Therapy Requires New Strategies for Cancer Drug Development
- New Discovery Halts Breast Cancer Stem Cells – Suggesting A New Drug Therapy Target
- New Therapy Provide Significant Survival Benefit In Second-line Metastatic Hormone-refractory Prostate Cancer (mHRPC)
- Cancer Tutorial: Introduction to Drug Resistance
- Scientists Unveil Genetic Code for Skin and Lung Cancer
Latest Blog Posts
- Fewer Infections and Less Clotting Associated with Neutral Fluid Displacement Connector
- Erlotinib is the First Personalized Medicine Approved for the Initial Treatment of People with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
- Angelina Jolie: A Difficult Choice and A Courageous Decision
- Enzastaurin Does Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma Study
- Study Evaluates Treatment of High Dose Aldesleukin + Vemurafenib in Patients with Metastatic Melanoma
- New Diagnostic Test Effectively Predicts Rapid Metastatic Prostate Cancer (RMD) - Outperforms Existing Tools
- UK Charity Calls for More Attention and Awareness for Bladder Cancer
Most Popular Blog Posts
- Newly Identified microRNAs Could be Biomarkers for Early Diagnosis of Progression of Barrett's Esophagus and Esophageal Adenocarcinoma
- Scientific Advisory Board of Patient Advocate Organizations Disagree with Changes to Mammography Guidelines
- First Ever Estimate Reveals the Direct and Indirect Economic Burden of Cancer in Europe
- Angelina Jolie: A Difficult Choice and A Courageous Decision
- PD-L1 Antibody MPDL3280A is well Tolerated in Phase I Study - No Limiting Toxicities Across a Range of Cancer Types
- Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) Shows Prolonged Progression Free Survival in High Risk, Advanced CLL/SLL and MCL Patients
- Expense and Unaffordable Leukemia Treatment May Harm Patients
Blog Topics by Tags
Monthly Archives
2013
2012
- December (32)
- November (19)
- October (17)
- September (9)
- August (10)
- July (4)
- June (29)
- May (16)
- April (6)
- March (4)
- February (21)
- January (38)
2011
- December (47)
- November (32)
- October (21)
- September (32)
- August (18)
- July (23)
- June (83)
- May (45)
- April (54)
- March (36)
- February (62)
- January (43)
2010
- December (58)
- November (49)
- October (65)
- September (23)
- August (7)
- July (4)
- June (34)
- May (7)
- April (7)
- March (5)
- February (3)
- January (6)
2009
2008
- December (19)
2007
- April (1)
2005
2004
- September (1)
2001
- November (1)
ADVERTISEMENT
Bookmark / Share
Join the Conversation!
© 2013 Created by Peter Hofland, PhD.
